Oxford Endovascular

Oxford Endovascular Ltd., a spin-out from the University of Oxford, aims to prevent brain bleeds caused by brain aneurysms, a condition that affects 1 in 50 people. OxiFlow™ is a novel next-generation flow diverter that redirects blood flow away from intracranial aneurysms at risk of rupture. It can be placed more accurately and safely than existing devices, reducing the risk of complications. Its better vessel conformability allows for the treatment of more patients.